AngioDynamics to Launch New Varicose Vein Therapy Brand
AngioDynamics, a provider of medical devices for treatment of cancer and peripheral vascular disease, has announced that it will launch a new varicose vein therapy brand, VenaCure EVLT.
According to the company, the new brand will encompass the best of AngioDynamics’s VenaCure product line as well as EVLT, a product line which the company recently rescued from the bankruptcy of Diomed.
The new line will now be available through AngioDynamics’s peripheral vascular division as a comprehensive package of innovative, minimally invasive medical devices for practices involved in the treatment of superficial venous disease. This includes the delta diode laser, a complete offering of procedure kits with the proprietary NeverTouch laser fiber, and accessories including the only FDA approved, commercially available sodium tetradecyl sulfate injection on the US market, Sotradecol.
In addition, AngioDynamics will be the only laser treatment provider to offer both total patient marketing support with its maximizing VenaCure potential (MVP) program and complete physician training with its VenaCure in practice program, the company said.
Sean Morris, senior vice president and general manager of peripheral vascular division at AngioDynamics, said: “We have now combined the best of Diomed and AngioDynamics into a dream team offering for physicians and their patients. Patients get an effective, outpatient alternative to otherwise painful and invasive surgery. Physicians get continuous support from AngioDynamics to develop their clinical practices and provide patients with the best treatment available.”